Clinical Trial Update: Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two immunomodulatory formulas to reduce postoperative infections in patients with head and neck cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Immunomodulatory Formula 1
• Immunomodulatory Formula 2

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Head and Neck Neoplasms | Phase 4 | Status: COMPLETED